Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Perfil epidemiológico dos casos de Hanseníase no estado do Piauí-Brasil

Sampaio APF, Costa RMPG. South Florida Publishing LLC. CONTRIBUCIONES A LAS CIENCIAS SOCIALES. 2023; 16 (10) : 24333-24343.
Download PDF
Publication

Verrucous Haemangioma with Histoid Leprosy: A Case Report

Mohan A, Ansari MH, Yadav V, et al. JCDR Research and Publications. Journal of Clinical and Diagnostic Research. 2023; 17 (9) : 1-3.
Download PDF
Publication

Supraorbital neuralgia in leprosy

Sharma S, Sharma P, Chandra UK, et al. BMJ. Practical Neurology. 2023;
Download PDF
Publication

Bartonella henselae as a putative trigger for chronic type 2 leprosy reactions.

Santos L, Drummond M, Goulart I, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2023; 27 (6) : 1-7.
Download PDF
Publication

Leprosy with type 1 reaction in a patient from Ontario, Canada without recent travel misdiagnosed as vasculitic neuropathy: a case report.

Driedger M, Teo I, Roth V. BMC infectious diseases. 2023; 23 (1) : 1-7.
Download PDF
Publication

Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy.

Chauffour A, Lounis N, Andries K, et al. PLoS neglected tropical diseases. 2023; 17 (11) : 1-10.
Download PDF
Publication

Case report: Cyclophosphamide pulse therapy for chronic recalcitrant erythema nodosum leprosum.

Machado G, Amparo T, Bulhões F, et al. Frontiers in medicine. 2023;
Download PDF
Publication

Evaluation of hematological parameters in patients with leprosy in Southern Nigeria.

Inyang I, Bassey I, Okoroiwu H. Germs. 2022; 12 (4) : 478-487.
Download PDF
Publication

Socio-historical representations of a disease: a study of posters from campaigns against Hansen's disease during the second half of the twentieth century.

Porto C, Marques M. Historia, ciencias, saude--Manguinhos. 2023;
Download PDF
Publication

Genome-wide meta-analysis and fine-mapping prioritize potential causal variants and genes related to leprosy.

Wang Z, Liu T, Li W, et al. MedComm. 2023; 4 (6) : 1-16.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 120
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD